stockrowBillionToOne, Inc. (BLLN) vs CareDx, Inc. (CDNA)
- BillionToOne, Inc. BLLN 113.28 +0.79%
- CareDx, Inc. CDNA 78.10 +2.32%
BillionToOne, Inc. and CareDx, Inc. are both Diagnostics & Research companies. BillionToOne, Inc. is the larger, with a market value of $5.3B against $4.0B — 1.3× the size. CareDx, Inc. trades at the lower P/E: 30.9× against 88.7×. BillionToOne, Inc. grew revenue faster over the last twelve months: 76.5% against 38.9%. CareDx, Inc. has the higher net margin (25.9% vs 11.2%) and the higher return on invested capital (33.6% vs 0.00%). Across the 19 metrics below, CareDx, Inc. leads on 14 and BillionToOne, Inc. on 5.
Valuation
Profitability
| Metric | BLLN | CDNA | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 71.41% | 70.97% | 48.32% |
| Operating margin | 10.23% | 23.42% | (5.68%) |
| Net margin | 11.23% | 25.86% | (4.10%) |
| Free cash flow margin | 7.76% | 12.01% | 0.00% |
| Return on equity | 0.00% | 33.04% | 0.00% |
| Return on assets | 9.02% | 23.96% | (6.05%) |
| Return on invested capital | 0.00% | 33.56% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack